Toxicity of MRI and CT contrast agents

@article{Hasebroock2009ToxicityOM,
  title={Toxicity of MRI and CT contrast agents},
  author={K. M. Hasebroock and N. Serkova},
  journal={Expert Opinion on Drug Metabolism & Toxicology},
  year={2009},
  volume={5},
  pages={403 - 416}
}
  • K. M. Hasebroock, N. Serkova
  • Published 2009
  • Medicine
  • Expert Opinion on Drug Metabolism & Toxicology
  • Anatomical and physiological imaging using CT and MRI are playing a critical role in patients’ diagnosis, disease characterization and treatment planning. CT- and MRI-based protocols increasingly require an injection of iodinated CT and gadolinium (Gd)-based MRI contrast media. Although routinely used in clinical practice, iodinated and to a less extent Gd-based contrast media possess side effects: life-threatening contrast-induced nephropathy (CIN) is associated with CT and nephrogenic… CONTINUE READING
    66 Citations
    Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue.
    • 113
    • PDF
    Nephrotoxic Polypharmacy and Risk of Contrast Medium-Induced Nephropathy in Hospitalized Patients Undergoing Contrast-Enhanced CT.
    • 8
    Albumin-mediated platinum nanocrystals for in vivo enhanced computed tomography imaging.
    • 12
    • PDF
    Translational imaging endpoints to predict treatment response to novel targeted anticancer agents.
    • N. Serkova
    • Medicine
    • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
    • 2011
    • 11

    References

    SHOWING 1-10 OF 104 REFERENCES
    Imaging patients with chronic kidney disease: CIN or NSF?
    • 18
    • Highly Influential
    Editorial: Gadolinium Use in Patients with Kidney Disease: A Cause for Concern
    • 81
    New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice.
    • 74
    Extracellular gadolinium-based contrast media: an overview.
    • 173
    • PDF
    Acute adverse reactions to magnetic resonance contrast media--gadolinium chelates.
    • 185
    Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents
    • 87
    • Highly Influential
    • PDF
    Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue.
    • 113
    • Highly Influential
    • PDF
    Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging.
    • 1,138
    • PDF